glp-1/gip receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight Schematic illustration of monoagonists, dual
Description
The Need for Further Research While this study establishes a strong association between GLP-1 drugs and ischemic optic neuropathy, more research is needed to determine causality and potential preventive measures
Others prioritize tournament calendars or mission-style challenges that reward exploration over repetitive spins
Htoo PT, Buse JB, Gokhale M, Marquis MA, Pate V, Strmer T
Extended data figures and tables Extended Data Fig
It carries a black box warning for suicidal ideation (inherited from the bupropion component), though this risk applies primarily to younger patients
Moreover, GLP-1RAs exhibit dose-dependent cardioprotective effects across different types of cardiomyopathy
